| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 2474-2480, Copyright © 1993 by Endocrine Society
ARTICLES |
T Emori, Y Hirata, T Imai, S Eguchi, K Kanno and F Marumo
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
We studied the cellular mechanism by which natriuretic peptides inhibit the synthesis and release of endothelin-1 (ET-1) in cultured rat aortic endothelial cells (EC). Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) showed dose-dependent and equipotent effects on displacement of [125I]ANP binding and generation of cGMP production in rat EC, whereas C-type natriuretic peptide and biologically inactive ANP analog had lesser effects. ANP and BNP as well as 8-bromo-cGMP had potent inhibitory effects on immunoreactive ET-1 release, the transient increase in the intracellular Ca2+ concentration, and the formation of inositol 1,4,5-trisphosphate stimulated by thrombin in rat EC. A cGMP- dependent protein kinase inhibitor (KT5823), but not a cAMP-dependent protein kinase inhibitor (KT5720), completely abolished the inhibitory effect of ANP on thrombin-induced immunoreactive Et-1 release. Northern blot analysis using cDNA for rat prepro-ET-1 as a probe showed that ANP and 8-bromo-cGMP, but not C-type natriuretic peptide, inhibited thrombin-induced prepro-ET-1 mRNA expression, whose effect was abolished by KT5823. These data suggest that ANP and BNP inhibit the thrombin-induced synthesis and release of ET-1 in cultured rat aortic EC by blocking phosphoinositide breakdown, possibly via natriuretic peptides type A receptor-mediated cGMP-dependent mechanism.
This article has been cited by other articles:
![]() |
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction J. Am. Coll. Cardiol., February 13, 2007; 49(6): 667 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ozawa, M. Shichiri, N. Fukai, T. Yoshimoto, and Y. Hirata Regulation of Adrenomedullin Gene Transcription and Degradation by the c-myc Gene Endocrinology, September 1, 2004; 145(9): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. ANTUNES-RODRIGUES, M. DE CASTRO, L. L. K. ELIAS, M. M. VALENCA, and S. M. McCANN Neuroendocrine Control of Body Fluid Metabolism Physiol Rev, January 1, 2004; 84(1): 169 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sabrane, S. Gambaryan, R. P. Brandes, R. Holtwick, M. Voss, and M. Kuhn Increased Sensitivity to Endothelial Nitric Oxide (NO) Contributes to Arterial Normotension in Mice with Vascular Smooth Muscle-selective Deletion of the Atrial Natriuretic Peptide (ANP) Receptor J. Biol. Chem., May 9, 2003; 278(20): 17963 - 17968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P.B. Wijayagunawardane, A. Miyamoto, Y. Taquahashi, T. J. Acosta, M. Nishimura, and K. Sato Angiotensin II and Atrial Natriuretic Peptide in the Cow Oviductal Contraction In Vitro: Direct Effect and Local Secretion of Prostaglandins, Endothelin-1, and Angiotensin II Biol Reprod, September 1, 2001; 65(3): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, T. Tsutsui, H. Horie, M. Ohnishi, and M. Kinoshita Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1820 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Sviri, M. Feinsod, and J. F. Soustiel Brain Natriuretic Peptide and Cerebral Vasospasm in Subarachnoid Hemorrhage : Clinical and TCD Correlations Stroke, January 1, 2000; 31(1): 118 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. van der Zander, A. J.H.M Houben, A. A Kroon, and P. W de Leeuw Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide Cardiovasc Res, December 1, 1999; 44(3): 595 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zellner, A. A. Protter, E. Ko, M. R. Pothireddy, T. DeMarco, S. J. Hutchison, T. M. Chou, K. Chatterjee, and K. Sudhir Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1049 - H1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suenobu, M. Shichiri, M. Iwashina, F. Marumo, and Y. Hirata Natriuretic Peptides and Nitric Oxide Induce Endothelial Apoptosis via a cGMP–Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bouchie, H. Hansen, and E. P. Feener Natriuretic Factors and Nitric Oxide Suppress Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells : Role of cGMP in the Regulation of the Plasminogen System Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1771 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Melo, A. T. Veress, U. Ackermann, and H. Sonnenberg Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1826 - H1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shichiri, S. Adachi, J. M. Sedivy, F. Marumo, and Y. Hirata Biphasic Regulation of the Preproendothelin-1 Gene by c-myc Endocrinology, November 1, 1997; 138(11): 4584 - 4590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shichiri, H. Kato, F. Marumo, and Y. Hirata Endothelin-1 as an Autocrine/Paracrine Apoptosis Survival Factor for Endothelial Cells Hypertension, November 1, 1997; 30(5): 1198 - 1203. [Abstract] [Full Text] |
||||
![]() |
H. Kato, M. Shichiri, F. Marumo, and Y. Hirata Adrenomedullin as an Autocrine/Paracrine Apoptosis Survival Factor for Rat Endothelial Cells Endocrinology, June 1, 1997; 138(6): 2615 - 2620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Draijer, A. B. Vaandrager, C. Nolte, H. R. de Jonge, U. Walter, and V. W.M. van Hinsbergh Expression of cGMP-Dependent Protein Kinase I and Phosphorylation of Its Substrate, Vasodilator-Stimulated Phosphoprotein, in Human Endothelial Cells of Different Origin Circ. Res., November 1, 1995; 77(5): 897 - 905. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |